No Data
No Data
KYORIN Pharmaceutical Upgrades Earnings Forecasts Following Licensing Deals
Express News | Kyorin Pharmaceutical -Revises 2024/25 Group Operating Forecast to Profit 12.50 Bln Yen From Profit 6.50 Bln Yen (+92.3%)
Express News | Kyorin Pharmaceutical -Revises 2024/25 Group Net Forecast to Profit 9.00 Bln Yen From Profit 5.00 Bln Yen (+80.0%)
Kyorin Pharmaceutical: Notice regarding revisions (upward revisions) to full-year earnings forecasts
Kyorin Pharmaceutical To Go Ex-Dividend On March 28th, 2025 With 32 JPY Dividend Per Share
March 27th (Japan Standard Time) - $Kyorin Pharmaceutical(4569.JP)$ is trading ex-dividend on March 28th, 2025.Shareholders of record on March 31st, 2025 will receive 32 JPY dividend per share. The
The Nikkei rose by 307 points, continuing to increase, with European Index-related stocks being bought, and over 80% of the Main Board stocks rising in the first half of the session.
Six days ago, the Nikkei average stock price rose by 307.78 yen compared to the previous day, reaching 37,726.02 yen, continuing its upward trend. The TOPIX (Tokyo Stock Price Index) also increased by 32.06 points to 2,750.27 points. On the 5th, the U.S. government announced that it would impose a 25% tariff on imports from Canada and Mexico, while granting a one-month grace period for automotive-related products. In the U.S. stock market, excessive caution regarding the U.S. economy has eased, leading to rebounds in both the Dow Inc and the Nasdaq Composite Index for the first time in three days. Japanese stocks are following this trend.